Vertex Pharmaceuticals (VRTX)

Total Costs & Expenses

$2.09B

Quarterly · Period ending: · USD

VRTX logo

VRTX Total Costs & Expenses

Latest reported$2.09B
VRTX Quarterly Total Costs & Expenses ($0.00 → $2.09B)
High-resolution chart · PNG

VRTX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
2,087,000,000
1,848,800,000
1,926,700,000
1,890,200,000
1,813,600,000
2,140,100,000
1,886,000,000
1,655,600,000
6,160,300,000
1,551,100,000
1,529,200,000
1,445,400,000
1,466,800,000
1,595,800,000
1,269,200,000
1,207,600,000
1,089,900,000
1,056,600,000
1,196,900,000
928,452,000
1,831,300,000
840,379,000
881,528,000
864,230,000
806,452,000
793,283,000
860,300,000
847,536,000
671,333,000
581,627,000
713,380,000
579,060,000
579,217,000
511,974,000
525,510,000
648,531,000
487,905,000
433,877,000
418,842,000
435,502,000
427,912,000
411,723,000
471,898,000
378,016,000
335,112,000
313,766,000
294,017,000
280,347,000
319,526,000
328,651,000
347,061,000
343,710,000
366,907,000
353,717,000
411,276,000
336,381,000
428,481,000
346,728,000
338,446,000
338,112,000
279,573,000
232,801,000
234,415,000
222,517,000
199,083,000
181,931,000
171,451,000
172,416,000
175,124,000
175,677,000
173,033,000
161,352,000
159,722,000
139,781,000
142,464,000
153,927,000
162,910,000
152,384,000
128,161,000
114,001,000
108,505,000
91,076,000
83,752,000
77,124,000
72,660,000
69,092,000
67,913,000
60,856,000
58,938,000
52,243,000
118,679,000
61,209,000
106,583,000
3,403,000
77,448,000
70,127,000
66,356,000
66,758,000
64,688,000
60,770,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.